182 related articles for article (PubMed ID: 38667330)
1. The Expression and Secretion Profile of TRAP5 Isoforms in Gaucher Disease.
Ivanova MM; Dao J; Loynab N; Noor S; Kasaci N; Friedman A; Goker-Alpan O
Cells; 2024 Apr; 13(8):. PubMed ID: 38667330
[TBL] [Abstract][Full Text] [Related]
2. TRAP5b and RANKL/OPG Predict Bone Pathology in Patients with Gaucher Disease.
Ivanova M; Dao J; Noll L; Fikry J; Goker-Alpan O
J Clin Med; 2021 May; 10(10):. PubMed ID: 34065531
[TBL] [Abstract][Full Text] [Related]
3. A Brazilian Rare-Disease Center's Experience with Glucosylsphingosine (lyso-Gb1) in Patients with Gaucher Disease: Exploring a Novel Correlation with IgG Levels in Plasma and a Biomarker Measurement in CSF.
Vernet Machado Bressan Wilke M; Iop GD; Faqueti L; Lemos da Silva LA; Kubaski F; Poswar FO; Michelin-Tirelli K; Randon D; Borelli WV; Giugliani R; Schwartz IVD
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474117
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneous pattern of bone disease in adult type 1 Gaucher disease: clinical and pathological correlates.
van Dussen L; Lips P; van Essen HW; Hollak CE; Bravenboer N
Blood Cells Mol Dis; 2014 Sep; 53(3):118-23. PubMed ID: 24947205
[TBL] [Abstract][Full Text] [Related]
5. Uncoupling of osteoblast-osteoclast regulation in a chemical murine model of Gaucher disease.
Mucci JM; Suqueli García F; de Francesco PN; Ceci R; Di Genaro S; Fossati CA; Delpino MV; Rozenfeld PA
Gene; 2013 Dec; 532(2):186-91. PubMed ID: 24076352
[TBL] [Abstract][Full Text] [Related]
6. Macrophage-derived soluble CD163 level in young patients with Gaucher disease: relation to phenotypes, disease severity and complications.
Adly AAM; Ismail EAR; Ibraheem TM
Int Immunopharmacol; 2015 Feb; 24(2):416-422. PubMed ID: 25587690
[TBL] [Abstract][Full Text] [Related]
7. Glucosylsphingosine is a highly sensitive and specific biomarker for primary diagnostic and follow-up monitoring in Gaucher disease in a non-Jewish, Caucasian cohort of Gaucher disease patients.
Rolfs A; Giese AK; Grittner U; Mascher D; Elstein D; Zimran A; Böttcher T; Lukas J; Hübner R; Gölnitz U; Röhle A; Dudesek A; Meyer W; Wittstock M; Mascher H
PLoS One; 2013; 8(11):e79732. PubMed ID: 24278166
[TBL] [Abstract][Full Text] [Related]
8. Gaucher iPSC-derived macrophages produce elevated levels of inflammatory mediators and serve as a new platform for therapeutic development.
Panicker LM; Miller D; Awad O; Bose V; Lun Y; Park TS; Zambidis ET; Sgambato JA; Feldman RA
Stem Cells; 2014 Sep; 32(9):2338-49. PubMed ID: 24801745
[TBL] [Abstract][Full Text] [Related]
9. Reductions in glucosylsphingosine (lyso-Gb1) in treatment-naïve and previously treated patients receiving velaglucerase alfa for type 1 Gaucher disease: Data from phase 3 clinical trials.
Elstein D; Mellgard B; Dinh Q; Lan L; Qiu Y; Cozma C; Eichler S; Böttcher T; Zimran A
Mol Genet Metab; 2017 Sep; 122(1-2):113-120. PubMed ID: 28851512
[TBL] [Abstract][Full Text] [Related]
10. Gaucher Disease Diagnosis Using Lyso-Gb1 on Dry Blood Spot Samples: Time to Change the Paradigm?
Dinur T; Bauer P; Beetz C; Kramp G; Cozma C; Iurașcu MI; Becker-Cohen M; Istaiti M; Rolfs A; Zimran A; Revel-Vilk S
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163551
[TBL] [Abstract][Full Text] [Related]
11. C5a Activates a Pro-Inflammatory Gene Expression Profile in Human Gaucher iPSC-Derived Macrophages.
Serfecz JC; Saadin A; Santiago CP; Zhang Y; Bentzen SM; Vogel SN; Feldman RA
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576075
[TBL] [Abstract][Full Text] [Related]
12. LC-MS/MS analysis of plasma glucosylsphingosine as a biomarker for diagnosis and follow-up monitoring in Gaucher disease in the Spanish population.
Irún P; Cebolla JJ; López de Frutos L; De Castro-Orós I; Roca-Espiau M; Giraldo P
Clin Chem Lab Med; 2020 Apr; 58(5):798-809. PubMed ID: 32126008
[TBL] [Abstract][Full Text] [Related]
13. Value of plasma chitotriosidase to assess non-neuronopathic Gaucher disease severity and progression in the era of enzyme replacement therapy.
van Dussen L; Hendriks EJ; Groener JE; Boot RG; Hollak CE; Aerts JM
J Inherit Metab Dis; 2014 Nov; 37(6):991-1001. PubMed ID: 24831585
[TBL] [Abstract][Full Text] [Related]
14. Glucosylsphingosine is a key biomarker of Gaucher disease.
Murugesan V; Chuang WL; Liu J; Lischuk A; Kacena K; Lin H; Pastores GM; Yang R; Keutzer J; Zhang K; Mistry PK
Am J Hematol; 2016 Nov; 91(11):1082-1089. PubMed ID: 27441734
[TBL] [Abstract][Full Text] [Related]
15. Metabolomic Study Using Time-of-Flight Mass Spectrometry Reveals Novel Urinary Biomarkers for Gaucher Disease Type 1.
Menkovic I; Boutin M; Alayoubi A; Curado F; Bauer P; Mercier FE; Auray-Blais C
J Proteome Res; 2022 May; 21(5):1321-1329. PubMed ID: 35349295
[TBL] [Abstract][Full Text] [Related]
16. Glucosylsphingosine (Lyso-Gb1) as a reliable biomarker in Gaucher disease: a narrative review.
Giuffrida G; Markovic U; Condorelli A; Calafiore V; Nicolosi D; Calagna M; Grasso S; Ragusa MTV; Gentile J; Napolitano M
Orphanet J Rare Dis; 2023 Feb; 18(1):27. PubMed ID: 36782327
[TBL] [Abstract][Full Text] [Related]
17. Impact of sphingolipids on osteoblast and osteoclast activity in Gaucher disease.
Reed MC; Schiffer C; Heales S; Mehta AB; Hughes DA
Mol Genet Metab; 2018 Aug; 124(4):278-286. PubMed ID: 29934064
[TBL] [Abstract][Full Text] [Related]
18. A Novel Sandwich ELISA for Tartrate-Resistant Acid Phosphatase 5a and 5b Protein Reveals that Both Isoforms are Secreted by Differentiating Osteoclasts and Correlate to the Type I Collagen Degradation Marker CTX-I In Vivo and In Vitro.
Mira-Pascual L; Patlaka C; Desai S; Paulie S; Näreoja T; Lång P; Andersson G
Calcif Tissue Int; 2020 Feb; 106(2):194-207. PubMed ID: 31654098
[TBL] [Abstract][Full Text] [Related]
19. Detection of glucosylsphingosine in dried blood spots for diagnosis of Gaucher disease by LC-MS/MS.
Tang C; Jia X; Tang F; Liu S; Jiang X; Zhao X; Sheng H; Peng M; Liu L; Huang Y
Clin Biochem; 2021 Jan; 87():79-84. PubMed ID: 33188770
[TBL] [Abstract][Full Text] [Related]
20. An observational study to investigate the relationship between plasma glucosylsphingosine (lyso-Gb1) concentration and treatment outcomes of patients with Gaucher disease in Japan.
Ida H; Watanabe Y; Sagara R; Inoue Y; Fernandez J
Orphanet J Rare Dis; 2022 Nov; 17(1):401. PubMed ID: 36329499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
